Treprostinil Injection, Solution
Product Images NDC 62332-516

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Treprostinil (NDC 62332-516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Treprostinil-1-mg-carton (Treprostinil 1 mg Carton)

Packaging label for Treprostinil Injection 20 mg/20 mL (1 mg/mL) solution, presented as a 20 mL multidose vial for subcutaneous or intravenous infusion. The label includes the NDC 62332-514-20 and lists Alembic Pharmaceuticals Inc. as the manufacturer, with manufacturing by Corden Pharma S.p.A. The label states storage instructions, inactive ingredients, and dosage directions labeled for prescription use only.*

FDA Label Image

Treprostinil-1-mg-vial (Treprostinil 1 mg Vial)

Label for Treprostinil Injection 20 mg/20 mL (1 mg/mL) solution for injection, indicated for subcutaneous or intravenous infusion. It is a 20 mL multidose vial labeled by Alembic Pharmaceuticals Inc., with manufacturing by Corden Pharma S.p.A, Italy. The label includes storage instructions, ingredient content per mL, and dosage note directing to package insert.*

FDA Label Image

Treprostinil-10-mg-carton (Treprostinil 10 mg Carton)

Packaging label for Treprostinil Injection 200 mg/20 mL (10 mg/mL) solution in a 20 mL multidose vial. The label specifies use for subcutaneous or intravenous infusion only and is manufactured for Alembic Pharmaceuticals Inc. It includes storage instructions, ingredient details, and barcode with NDC 62332-517-20.*

FDA Label Image

Treprostinil-10-mg-vial (Treprostinil 10 mg Vial)

Label for Treprostinil Injection 200 mg/20 mL (10 mg/mL) multidose vial by Alembic Pharmaceuticals Inc. Intended for subcutaneous or intravenous infusion only. Includes active ingredient concentration, storage instructions, manufacturer information, barcode, and space for lot, manufacturing, and expiry dates. Multiple strengths also referenced in product data.*

FDA Label Image

Treprostinil-2-5-mg-carton (Treprostinil 2 5 mg Carton)

Packaging label for Treprostinil Injection 50 mg/20 mL (2.5 mg/mL) solution for injection by Alembic Pharmaceuticals Inc. The label indicates it is for subcutaneous or intravenous infusion only, supplied in a 20 mL multidose vial. Storage instructions, manufacturing details for Alembic Pharmaceuticals Inc. and Corden Pharma S.p.A. in Italy, and ingredient information are also visible.*

FDA Label Image

Treprostinil-2-5-mg-vial (Treprostinil 2 5 mg Vial)

Label for Treprostinil Injection 50 mg/20 mL (2.5 mg/mL) solution for subcutaneous or intravenous infusion. The 20 mL multidose vial label indicates it is manufactured for Alembic Pharmaceuticals Inc. and by Corden Pharma S.p.A., Italy. The label includes active ingredient amount per mL, storage instructions, and barcode.*

FDA Label Image

Treprostinil-5-mg-carton (Treprostinil 5 mg Carton)

Packaging label for Treprostinil Injection 100 mg/20 mL (5 mg/mL) solution for injection. The product is for subcutaneous or intravenous infusion only, supplied in a 20 mL multidose vial. Labeler is Alembic Pharmaceuticals Inc., manufactured by Corden Pharma S.p.A. The label includes storage instructions, dosage direction to see package insert, and lists inactive ingredients. The Alembic logo and bar code with NDC 62332-516-20 are also present.*

FDA Label Image

Treprostinil-5-mg-vial (Treprostinil 5 mg Vial)

Treprostinil Injection 100 mg/20 mL (5 mg/mL) solution for injection in a 20 mL multidose vial. This label specifies use for subcutaneous or intravenous infusion only. The product is manufactured for Alembic Pharmaceuticals Inc. and by Corden Pharma S.p.A. The label includes storage instructions, ingredient details, and barcode information.*

FDA Label Image

Treprostinil-image-1 (Treprostinil Image 1)

A Kaplan-Meier survival curve showing the percentage of subjects without a clinical deterioration event over days on study, comparing Treprostinil Injection versus placebo. The plot displays a higher percentage event-free for Treprostinil Injection over approximately 55 days, with a statistically significant p-value of 0.000228.*

FDA Label Image

Treprostinil-structure (Treprostinil Structure)

Chemical structure of Treprostinil showing its detailed molecular arrangement, with molecular formula C23H34O5 and molecular weight 390.52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.